Cargando…
Adenosine receptor signalling in Alzheimer’s disease
Alzheimer’s disease (AD) is the most common dementia in the elderly and its increasing prevalence presents treatment challenges. Despite a better understanding of the disease, the current mainstay of treatment cannot modify pathogenesis or effectively address the associated cognitive and memory defi...
Autores principales: | Trinh, Phuc N. H., Baltos, Jo-Anne, Hellyer, Shane D., May, Lauren T., Gregory, Karen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391555/ https://www.ncbi.nlm.nih.gov/pubmed/35870032 http://dx.doi.org/10.1007/s11302-022-09883-1 |
Ejemplares similares
-
Publisher Correction to: Adenosine receptor signalling in Alzheimer’s disease
por: Trinh, Phuc N. H., et al.
Publicado: (2022) -
Small molecule allosteric modulation of the adenosine A(1) receptor
por: Nguyen, Anh T. N., et al.
Publicado: (2023) -
Targeting Adenosine Receptor Signaling in Cancer Immunotherapy
por: Sek, Kevin, et al.
Publicado: (2018) -
Caffeine for Prevention of Alzheimer’s Disease: Is the A(2A) Adenosine Receptor Its Target?
por: Merighi, Stefania, et al.
Publicado: (2023) -
Pathophysiological Role and Medicinal Chemistry of A(2A) Adenosine Receptor Antagonists in Alzheimer’s Disease
por: Merighi, Stefania, et al.
Publicado: (2022)